Review article · 2020 · Open access

Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives

Étienne Crickx, Jean–Claude Weill, Claude–Agnès Reynaud, Matthieu Mahévas

Kidney International, 97(5), 885–893 · Published 30 January 2020 · DOI 10.1016/j.kint.2019.12.025

Open PDFView at the publisherCite this paper

In brief

“Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives” is a 2020 review article by Étienne Crickx and 3 co-authors, published in Kidney International. OpenAlex counts 120 citations as of 20 November 2026, which puts it in the top 5% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Kidney International.

Citations
120
Most cited in
2025 (41)
Field-weighted impact
1.06
References
111
Authors
4

Abstract

B-cell depletion with anti-CD20 monoclonal antibodies is widely used for the treatment of autoimmune diseases. This review will discuss mechanisms contributing to success or failure of B-cell depletion therapy in antibody-mediated autoimmune diseases. It will also explain how key information about disease pathogeny can be provided by the different outcomes observed after B-cell depletion therapy. These findings provide the basis for future innovative therapeutic strategies aiming at an optimized B cell and/or plasma cell depletion to increase long-term disease remission.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Crickx, É., Weill, J., Reynaud, C., & Mahévas, M. (2020). Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives. Kidney International, 97(5), 885–893. https://doi.org/10.1016/j.kint.2019.12.025

MLA 9

Crickx, Étienne, et al. “Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives.” Kidney International, vol. 97, no. 5, 2020, pp. 885–893. https://doi.org/10.1016/j.kint.2019.12.025.

Chicago

Crickx, Étienne, Jean–Claude Weill, Claude–Agnès Reynaud, and Matthieu Mahévas. 2020. “Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives.” Kidney International 97 (5): 885–893. https://doi.org/10.1016/j.kint.2019.12.025.

Harvard

Crickx, É. et al. (2020) ‘Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives’, Kidney International, 97(5), pp. 885–893. doi:10.1016/j.kint.2019.12.025.

IEEE

É. Crickx, J. Weill, C. Reynaud, and M. Mahévas, “Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives,” Kidney International, vol. 97, no. 5, pp. 885–893, 2020, doi: 10.1016/j.kint.2019.12.025.

BibTeX

@article{crickx2020anti,
  title     = {{Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives}},
  author    = {Crickx, Étienne and Weill, Jean–Claude and Reynaud, Claude–Agnès and Mahévas, Matthieu},
  journal   = {Kidney International},
  year      = {2020},
  volume    = {97},
  number    = {5},
  pages     = {885--893},
  doi       = {10.1016/j.kint.2019.12.025},
  url       = {https://doi.org/10.1016/j.kint.2019.12.025}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202033
202188
202288
20231212
20242626
20254141
20262222

Its field-weighted citation impact is 1.06: it has been cited 1.06 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research

  • anti-CD20 monoclonal antibody
  • B-cell depletion therapy
  • autoimmune disease
  • antibody-mediated autoimmunity
  • B cells
  • plasma cells
  • remission
  • treatment failure

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Crickx, É., Weill, J., Reynaud, C., & Mahévas, M. (2020). Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives. Kidney International, 97(5), 885–893. https://doi.org/10.1016/j.kint.2019.12.025

How many times has this paper been cited?

120 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Kidney International: sign in and open the PDF from this page.

Who wrote this paper?

Étienne Crickx, Jean–Claude Weill, Claude–Agnès Reynaud, Matthieu Mahévas.

What is the DOI of this paper?

10.1016/j.kint.2019.12.025, permanently at https://doi.org/10.1016/j.kint.2019.12.025. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.